Vori Health members get playlists of personalized exercises like this one to build strength and restore motion. This exercise strengthens your hips and can help reduce low back pain.
Obesity and musculoskeletal (MSK) conditions impact a major portion of the American population. With glucagon-like peptide-1 agonists (GLP-1s) rapidly transforming obesity care as well as bottom lines, it's more important than ever for employers and payers to consider strategies for sustainable impact.
Hear Vori Health CEO Ryan A. Grant, MD, MBA, FAANS and David Essary, President of Allstate Benefits, discuss the rising costs of MSK care, why the delivery of care model matters, and how to compare the different offerings in the market for employers/plans.
Hear Vori Health CEO Ryan A. Grant, MD, MBA, FAANS and David Essary, President of Allstate Benefits, discuss the rising costs of MSK care, why the delivery of care model matters, and how to compare the different offerings in the market for employers/plans.
With healthcare costs continuing to balloon into the new year, employers and plans should challenge their vendors and solutions to determine the true value of their programs. While improvements in program satisfaction and qualitative outcomes are helpful indicators, the only way to perform a concrete analysis is by tracking return on investment (ROI).
As cut points rise and star ratings fall, the next step for MA plan leaders is to identify low-hanging fruit where measure-level improvements can drive a significant increase in plan value. In order to move the needle, providing members access to high-quality MSK care is an excellent first step.
Healthcare leaders from Independent Health, Evry Health, BlueCross BlueShield of Illinois, and Vori Health discuss GLP-1s and their role in addressing the global challenge of obesity while considering the crucial aspect of musculoskeletal (MSK) health. Learn innovative, multidisciplinary strategies you can implement to complement lifestyle interventions and other therapeutic approaches in your organization.
When you solve a problem at its root, you get better outcomes. We built our award-winning, patient-centered care model for MSK conditions upon this premise, and we are thrilled to report the revalidation of its clinical outcomes from the Validation Institute.
Pearl Health and Vori Health partner to improve back, neck, and orthopedic care for Traditional Medicare patients and simplify access to appropriate, evidence-based care.
2024 is fast approaching, meaning it’s time to look back and reflect on the wins, losses, and emerging trends that defined 2023 and will shape the musculoskeletal (MSK) industry in the coming year. Read on for what value-based care strategies Vori Health co-founders, Ryan Grant, MD, and Mary O'Connor, MD have to share.
Vori Health, a nationwide virtual-first specialty medical practice and industry leader in the treatment of muscle and joint pain today announced a partnership with Contigo Health, a health benefits platform that leads direct-to-employer and direct-to-provider relationships, to create a comprehensive musculoskeletal (MSK) benefit solution.
The United States population is aging quickly—a change driven by a booming segment of older adults (age 65 and above), which recorded the fastest growth rate in the past 10 years since the late 19th century. This shift has huge implications for healthcare. The industry must quickly determine how to handle dramatic upswings in utilization rates stemming from age-related conditions.
Telehealth has proven to be a significant cost-effective care model for not only employers, but employees as well. With the right virtual solution, employers can bring significant savings and effective MSK care right to their employees’ fingertips.
If the last few years have taught us anything, it’s the importance of high-value, accessible healthcare. By shifting visits from offices to online platforms, the pandemic accelerated the adoption of telehealth and opened doors to a different kind of care—one that prioritizes member satisfaction above all else.
Vori Health sets new bar of excellence in MSK industry by earning URAC accreditation as a credentials verification organization (CVO).
Ophelia and Vori Health partner to improve access to high-quality, safe opioid use disorder (OUD) care services for patients suffering from chronic pain and opioid addiction as well as people in recovery who are looking for opioid-free MSK care.
As the healthcare industry shifts to more value-based and patient-centered care, the issue of access to medical services has surfaced as a critical concern for many Medicare Advantage plan members. To bolster Star ratings in the coming years, MA plans must take swift action to implement solutions that improve access to needed care—especially when it comes to treating back and joint pain.
In honor of Pain Awareness Month and Opioid Awareness Day, Vori Health and Ophelia are teaming up to spread awareness of the connection between chronic pain and opioid addiction. Opioid-related overdose deaths have more than doubled in the last six years. The trend is expected to continue, especially as many patients with opioid addiction have struggled to access FDA-approved medications for treatment such as buprenorphine.
Value-based care initiatives can only be sustainable if patient outcomes are a top priority. By carefully assessing the impact of solutions on patients, the healthcare industry as a whole can work towards reducing the cost of care while delivering meaningful value.
Low back pain affects millions of people worldwide and is projected to continue to grow as a leading cause of disability. This increase in prevalence rates leads to a negative impact on employee well-being, workplace productivity, and healthcare utilization—creating significant harm to an employer's bottom line.